Coronary artery stenosis is a medical condition characterized by the narrowing of one or more of the coronary arteries that supply blood to the heart muscle. This narrowing occurs due to the accumulation of fatty deposits, cholesterol, and other substances, collectively known as plaque, on the inner walls of the arteries. As the plaque builds up, it can restrict blood flow to the heart, leading to a reduction in oxygen and nutrients reaching the cardiac muscles. This diminished blood supply may result in chest pain or angina, and in severe cases, it can lead to a heart attack. Coronary artery stenosis is often associated with atherosclerosis, a chronic inflammatory condition that affects the arteries throughout the body. Lifestyle factors such as a poor diet, lack of physical activity, and smoking, as well as genetic predispositions, contribute to the development of this condition. Management of coronary artery stenosis typically involves lifestyle modifications, medications, and, in some cases, surgical interventions such as angioplasty or coronary artery bypass grafting to restore blood flow to the heart muscle. Early detection and intervention are crucial for preventing complications and preserving heart health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India